title: Genomic association analysis suggests chromosome 12 locus influencing antihypertensive response to thiazide diuretic.
abstract: We conducted a genome-wide association study to identify novel genes influencing diastolic blood pressure (BP) response to hydrochlorothiazide, a commonly prescribed thiazide diuretic preferred for the treatment of high BP. Affymetrix GeneChip Human Mapping 100K Arrays were used to measure single nucleotide polymorphisms across the 22 autosomes in 194 non-Hispanic black subjects and 195 non-Hispanic white subjects with essential hypertension selected from opposite tertiles of the race- and sex-specific distributions of age-adjusted diastolic BP response to hydrochlorothiazide (25 mg daily, PO, for 4 weeks). The black sample consisted of 97 "good" responders (diastolic BP response [mean+/-SD]=-18.3+/-4.2 mm Hg; age=47.1+/-6.1 years; 51.5% women) and 97 "poor" responders (diastolic BP response=-0.18+/-4.3; age=47.4+/-6.5 years; 51.5% women). Haplotype trend regression identified a region of chromosome 12q15 in which haplotypes constructed from 3 successive single nucleotide polymorphisms (rs317689, rs315135, and rs7297610) in proximity to lysozyme (LYZ), YEATS domain containing 4 (YEATS4), and fibroblast growth receptor substrate 2 (FRS2) were significantly associated with diastolic BP response (nominal P=2.39 x 10(-7); Bonferroni corrected P=0.024; simulated experiment-wise P=0.040). Genotyping of 35 additional single nucleotide polymorphisms selected to "tag" linkage disequilibrium blocks in these genes provided corroboration that variation in LYZ and YEATS4 was associated with diastolic BP response in a statistically independent data set of 291 black subjects and in the sample of 294 white subjects. These results support the use of genome-wide association analyses to identify novel genes influencing antihypertensive drug responses.
authors.affiliation: Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA. turner.stephen@mayo.edu
authors.forename: Stephen T
authors.initials: ST
authors.lastname: Turner
authors.forename: Kent R
authors.initials: KR
authors.lastname: Bailey
authors.forename: Brooke L
authors.initials: BL
authors.lastname: Fridley
authors.forename: Arlene B
authors.initials: AB
authors.lastname: Chapman
authors.forename: Gary L
authors.initials: GL
authors.lastname: Schwartz
authors.forename: High Seng
authors.initials: HS
authors.lastname: Chai
authors.forename: Hugues
authors.initials: H
authors.lastname: Sicotte
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Kocher
authors.forename: Andréi S
authors.initials: AS
authors.lastname: Rodin
authors.forename: Eric
authors.initials: E
authors.lastname: Boerwinkle
mesh_terms: D000328:Adult; D044383:Black People / Q000235:genetics; D001795:Blood Pressure Determination; D016022:Case-Control Studies; D002881:Chromosomes, Human, Pair 12; D005260:Female; D005500:Follow-Up Studies; D020022:Genetic Predisposition to Disease; D016678:Genome; D006801:Humans; D006852:Hydrochlorothiazide / Q000008:administration & dosage*; D006973:Hypertension / Q000188:drug therapy* / Q000453:epidemiology / Q000235:genetics*; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D010597:Pharmacogenetics; D011110:Polymorphism, Genetic; D011336:Probability; D018570:Risk Assessment; D016896:Treatment Outcome; D044465:White People / Q000235:genetics
chemical_list: D006852:Hydrochlorothiazide